Chemcrux September-quarter profit rises to Rs 1.62 crore

Chemcrux Enterprises Limited reported standalone profit for the period of Rs 1.62 crore for the quarter ended 30 September 2026, up from Rs 79.95 lakh a year earlier. Revenue from operations rose to Rs 23.84 crore from Rs 18.55 crore, while half-year net operating cash flow increased to Rs 13.10 crore from Rs 5.54 crore.

How much did Chemcrux profit rise in the September quarter?

Chemcrux’s standalone profit for the period rose by Rs 82.47 lakh year on year to Rs 1.62 crore in the quarter ended 30 September 2026. Profit before tax increased to Rs 2.18 crore from Rs 98.27 lakh, and total comprehensive income rose to Rs 1.87 crore from Rs 99.39 lakh.

The higher profit followed an increase in total income to Rs 24.15 crore from Rs 19.35 crore, while total expenses rose to Rs 21.97 crore from Rs 18.37 crore. The tax charge increased to Rs 55.89 lakh from Rs 18.32 lakh, comprising current tax of Rs 47 lakh and deferred tax of Rs 8.89 lakh in the latest quarter.

Basic and diluted earnings per share were each Rs 1.10 for the September 2026 quarter, compared with Rs 0.54 in the corresponding quarter of 2025. Chemcrux said the effect of employee stock options on diluted earnings per share was not material, so basic and diluted figures were the same after rounding under Indian Accounting Standard 33.

What changed in Chemcrux revenue and costs?

Chemcrux reported a Rs 5.29 crore increase in quarterly revenue from operations, reaching Rs 23.84 crore for the quarter ended 30 September 2026. Other income was Rs 30.63 lakh, down from Rs 79.81 lakh a year earlier, meaning the increase in total income was primarily reflected in revenue from operations.

Cost of materials consumed increased to Rs 10.84 crore from Rs 7.58 crore, employee benefits expense rose to Rs 2.60 crore from Rs 2.11 crore, and other expenses increased to Rs 7.62 crore from Rs 5.31 crore. Depreciation and amortisation were broadly unchanged at Rs 96.16 lakh, compared with Rs 96.26 lakh in the year-earlier quarter.

The inventory-change line moved to negative Rs 38.90 lakh in the September 2026 quarter, compared with an expense of Rs 1.89 crore a year earlier. Finance costs fell to Rs 33.95 lakh from Rs 52.02 lakh, while total expenses increased by Rs 3.60 crore, less than the Rs 4.80 crore rise in total income.

For the half year ended 30 September 2026, Chemcrux reported revenue from operations of Rs 45.78 crore, compared with Rs 35.30 crore in the prior-year half. Half-year profit for the period rose to Rs 3 crore from Rs 1.38 crore, while profit before tax increased to Rs 4.03 crore from Rs 1.71 crore.

How did Chemcrux perform compared with the June quarter?

Chemcrux’s September-quarter profit increased from Rs 1.37 crore in the quarter ended 30 June 2026 to Rs 1.62 crore. Revenue from operations rose from Rs 21.94 crore to Rs 23.84 crore, and profit before tax increased from Rs 1.85 crore to Rs 2.18 crore.

The September quarter’s total income was Rs 24.15 crore, compared with Rs 22.25 crore in the June quarter, while total expenses increased to Rs 21.97 crore from Rs 20.40 crore. This left a pre-tax profit increase of Rs 33.23 lakh across the two quarters.

Materials consumed rose to Rs 10.84 crore from Rs 8.28 crore and other expenses increased to Rs 7.62 crore from Rs 6.55 crore. However, the inventory-change line shifted from an expense of Rs 1.68 crore in June to negative Rs 38.90 lakh in September; finance costs were Rs 33.95 lakh, compared with Rs 34.31 lakh.

Other income was Rs 30.63 lakh in the September quarter and Rs 30.93 lakh in the June quarter. Employee benefits expense was largely unchanged at Rs 2.60 crore, compared with Rs 2.59 crore, and depreciation and amortisation was Rs 96.16 lakh against Rs 95.27 lakh.

What do Chemcrux cash flow and balance-sheet figures show?

Chemcrux generated net cash from operating activities of Rs 13.10 crore in the half year ended 30 September 2026, compared with Rs 5.54 crore in the half year ended 30 September 2025. Cash generated from operations was Rs 13.53 crore, after which direct taxes paid, net of refunds, were Rs 43.13 lakh.

The cash-flow statement showed operating profit before working-capital changes of Rs 5.47 crore for the latest half year, versus Rs 3.58 crore a year earlier. Net cash used in investing activities was Rs 4.14 crore, compared with net cash generated of Rs 28.84 lakh in the prior-year period, while net cash used in financing activities was Rs 3.12 crore.

Cash and cash equivalents on Chemcrux’s standalone balance sheet stood at Rs 8.27 crore at 30 September 2026, up from Rs 2.43 crore at 31 March 2026. Current investments rose to Rs 20.25 crore from Rs 15.88 crore, whereas trade receivables declined to Rs 15.30 crore from Rs 19.25 crore.

Long-term borrowings declined to Rs 11.79 crore at 30 September 2026 from Rs 13.25 crore at 31 March 2026. Short-term borrowings increased to Rs 8.93 crore from Rs 8.47 crore, and total standalone assets rose to Rs 123.87 crore from Rs 117.69 crore.

What accounting and business matters did Chemcrux disclose?

Chemcrux said it manufactures and processes bulk drug intermediates and treats this activity as a single operating segment under Indian Accounting Standard 108. The filing therefore did not provide separate segment-level revenue or profit figures for the quarter ended 30 September 2026.

On 15 May 2026, Chemcrux granted 107,700 employee stock options under the Chemcrux Enterprises Employee Stock Option Scheme 2025. The options carry an exercise price of Rs 10 each and a one-year vesting period, and the company recognised a proportionate share-based payment expense using management’s estimated grant-date fair value.

The statutory auditor’s limited-review report noted that the final fair value from an independent registered valuer remains pending. Management said any adjustment arising from the final valuation is not expected to be material and will be recognised prospectively in subsequent quarters of the current financial year.

Chemcrux also said the New Labour Codes took effect on 21 November 2025 and that its employee-benefit structures, including gratuity, had been aligned with requirements as at 31 March 2026. The company said the implementation had no material impact on standalone results for the quarter and half year ended 30 September 2026.

Conclusion

Chemcrux’s September-quarter filing shows higher revenue and a Rs 1.62 crore standalone profit, compared with Rs 79.95 lakh a year earlier. The half-year comparison also shows revenue increasing by Rs 10.48 crore and net operating cash flow increasing by Rs 7.55 crore, while long-term borrowings fell by Rs 1.46 crore from 31 March 2026.

The next disclosed matter to watch is the final independent valuation of the 107,700 options granted on 15 May 2026. Chemcrux has said any accounting adjustment from that report would be recorded prospectively in subsequent quarters of the current financial year and is not expected by management to be material.